{"id":"https://openalex.org/W2017136132","doi":"https://doi.org/10.1016/j.bmcl.2008.08.038","title":"Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase","display_name":"Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase","alternate_titles":[],"publication_year":2008,"publication_date":"2008-08-15","ids":{"openalex":"https://openalex.org/W2017136132","doi":"https://doi.org/10.1016/j.bmcl.2008.08.038","mag":"2017136132","pmid":"https://pubmed.ncbi.nlm.nih.gov/18774711"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2008.08.038","doi":"https://doi.org/10.1016/j.bmcl.2008.08.038","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2008.08.038","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic &amp; Medicinal Chemistry Letters","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2017136132"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035630082","display_name":"Jeffrey Y. Melamed","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jeffrey Y. Melamed","raw_affiliation_strings":["Department of Medicinal Chemistry, Merck Research Laboratories, 770 Sumneytown Pike, PO Box 4, West Point, PA 19486, USA. jeffrey_melamed@merck.com","Department of Medicinal Chemistry, Merck Research Laboratories, 770 Sumneytown Pike, PO Box 4, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Merck Research Laboratories, 770 Sumneytown Pike, PO Box 4, West Point, PA 19486, USA. jeffrey_melamed@merck.com","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Department of Medicinal Chemistry, Merck Research Laboratories, 770 Sumneytown Pike, PO Box 4, West Point, PA 19486, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090298784","display_name":"Melissa S. Egbertson","orcid":"https://orcid.org/0000-0001-7968-676X","observed_orcids":["https://orcid.org/0000-0001-7968-676X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melissa S. Egbertson","raw_affiliation_strings":["Department of Medicinal Chemistry, Merck Research Laboratories, 770 Sumneytown Pike, PO Box 4, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Merck Research Laboratories, 770 Sumneytown Pike, PO Box 4, West Point, PA 19486, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109908310","display_name":"Sandor L. Varga","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandor Varga","raw_affiliation_strings":["Department of Medicinal Chemistry, Merck Research Laboratories, 770 Sumneytown Pike, PO Box 4, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Merck Research Laboratories, 770 Sumneytown Pike, PO Box 4, West Point, PA 19486, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112471086","display_name":"Joseph P. Vacca","orcid":"https://orcid.org/0000-0003-0794-1527","observed_orcids":["https://orcid.org/0000-0003-0794-1527"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph P. Vacca","raw_affiliation_strings":["Department of Medicinal Chemistry, Merck Research Laboratories, 770 Sumneytown Pike, PO Box 4, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Merck Research Laboratories, 770 Sumneytown Pike, PO Box 4, West Point, PA 19486, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068760415","display_name":"Gregory Moyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Greg Moyer","raw_affiliation_strings":["Department of Viral Vaccine Research, Merck Research Laboratories, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Viral Vaccine Research, Merck Research Laboratories, West Point, PA 19486, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109954336","display_name":"Lori J. Gabryelski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lori Gabryelski","raw_affiliation_strings":["Department of Viral Vaccine Research, Merck Research Laboratories, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Viral Vaccine Research, Merck Research Laboratories, West Point, PA 19486, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071262396","display_name":"Peter J. Felock","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter J. Felock","raw_affiliation_strings":["Department of Antiviral Research, Merck Research Laboratories, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Antiviral Research, Merck Research Laboratories, West Point, PA 19486, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047027250","display_name":"Kara A. Stillmock","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kara A. Stillmock","raw_affiliation_strings":["Department of Antiviral Research, Merck Research Laboratories, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Antiviral Research, Merck Research Laboratories, West Point, PA 19486, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082273296","display_name":"Marc V. Witmer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marc V. Witmer","raw_affiliation_strings":["Department of Antiviral Research, Merck Research Laboratories, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Antiviral Research, Merck Research Laboratories, West Point, PA 19486, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030101432","display_name":"William A. Schleif","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Schleif","raw_affiliation_strings":["Department of Viral Vaccine Research, Merck Research Laboratories, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Viral Vaccine Research, Merck Research Laboratories, West Point, PA 19486, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088571596","display_name":"Daria J. Hazuda","orcid":"https://orcid.org/0000-0002-6894-1056","observed_orcids":["https://orcid.org/0000-0002-6894-1056"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daria J. Hazuda","raw_affiliation_strings":["Department of Antiviral Research, Merck Research Laboratories, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Antiviral Research, Merck Research Laboratories, West Point, PA 19486, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053355037","display_name":"Yvonne M. Leonard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yvonne Leonard","raw_affiliation_strings":["Department of Drug Metabolism, Merck Research Laboratories, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Metabolism, Merck Research Laboratories, West Point, PA 19486, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008009084","display_name":"Lixia Jin","orcid":"https://orcid.org/0000-0001-8018-9779","observed_orcids":["https://orcid.org/0000-0001-8018-9779"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lixia Jin","raw_affiliation_strings":["Department of Drug Metabolism, Merck Research Laboratories, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Metabolism, Merck Research Laboratories, West Point, PA 19486, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032314515","display_name":"Joan D. Ellis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joan D. Ellis","raw_affiliation_strings":["Department of Drug Metabolism, Merck Research Laboratories, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Metabolism, Merck Research Laboratories, West Point, PA 19486, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072588174","display_name":"Steven D. Young","orcid":"https://orcid.org/0009-0006-9427-891X","observed_orcids":["https://orcid.org/0009-0006-9427-891X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven D. Young","raw_affiliation_strings":["Department of Medicinal Chemistry, Merck Research Laboratories, 770 Sumneytown Pike, PO Box 4, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Merck Research Laboratories, 770 Sumneytown Pike, PO Box 4, West Point, PA 19486, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5035630082"],"corresponding_institution_ids":["https://openalex.org/I1285764155"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":1.571,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.8163128,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"18","issue":"19","first_page":"5307","last_page":"5310"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-integrase-inhibitors","display_name":"HIV-1 integrase inhibitors","score":0.9940000176429749},{"id":"https://openalex.org/keywords/pyrrolidone-derivatives","display_name":"pyrrolidinone derivatives","score":0.8270000219345093},{"id":"https://openalex.org/keywords/1-6-naphthyridines","display_name":"1,6-naphthyridines","score":0.765999972820282},{"id":"https://openalex.org/keywords/strand-transfer-inhibition","display_name":"strand transfer inhibition","score":0.8230000138282776},{"id":"https://openalex.org/keywords/two-pot-synthesis","display_name":"two-pot synthesis","score":0.7799999713897705},{"id":"https://openalex.org/keywords/antiviral-agents","display_name":"antiviral agents","score":0.7059999704360962},{"id":"https://openalex.org/keywords/viral-dna-integration","display_name":"viral DNA integration","score":0.6169999837875366}],"concepts":[{"id":"https://openalex.org/C14430832","wikidata":"https://www.wikidata.org/wiki/Q412550","display_name":"Integrase","level":3,"score":0.915574312210083},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8521977663040161},{"id":"https://openalex.org/C2778327999","wikidata":"https://www.wikidata.org/wiki/Q188777","display_name":"Carboxamide","level":2,"score":0.7894073724746704},{"id":"https://openalex.org/C2777302000","wikidata":"https://www.wikidata.org/wiki/Q412251","display_name":"Integrase inhibitor","level":5,"score":0.6111515164375305},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5649274587631226},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.5149617791175842},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.4472167491912842},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.37753912806510925},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.3363131880760193},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1806849241256714},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.17687520384788513},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.1698036789894104},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08634507656097412},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009287","descriptor_name":"Naphthyridines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D009287","descriptor_name":"Naphthyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009287","descriptor_name":"Naphthyridines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D019427","descriptor_name":"HIV Integrase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019428","descriptor_name":"HIV Integrase Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D019428","descriptor_name":"HIV Integrase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019428","descriptor_name":"HIV Integrase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bmcl.2008.08.038","doi":"https://doi.org/10.1016/j.bmcl.2008.08.038","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2008.08.038","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic &amp; Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:18774711","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18774711","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1600632000","https://openalex.org/W2053125329","https://openalex.org/W2073031487","https://openalex.org/W2087400133","https://openalex.org/W2107775218","https://openalex.org/W2126573810","https://openalex.org/W2132185205","https://openalex.org/W2140596752","https://openalex.org/W2171711893"],"related_works":["https://openalex.org/W2107775218","https://openalex.org/W1971075278","https://openalex.org/W2072692397","https://openalex.org/W2086295635","https://openalex.org/W2804291220","https://openalex.org/W2059458343","https://openalex.org/W2063889189","https://openalex.org/W2060921417","https://openalex.org/W2092853999","https://openalex.org/W2074470418"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2017136132","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
